These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11291055)

  • 61. Linker-based GnRH-PE chimeric proteins inhibit cancer growth in nude mice.
    Ben-Yehudah A; Yarkoni S; Nechushtan A; Belostotsky R; Lorberboum-Galski H
    Med Oncol; 1999 Apr; 16(1):38-45. PubMed ID: 10382941
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Adenocarcinoma cells are targeted by the new GnRH-PE66 chimeric toxin through specific gonadotropin-releasing hormone binding sites.
    Nechushtan A; Yarkoni S; Marianovsky I; Lorberboum-Galski H
    J Biol Chem; 1997 Apr; 272(17):11597-603. PubMed ID: 9111076
    [TBL] [Abstract][Full Text] [Related]  

  • 63. GnRH-Bik/Bax/Bak chimeric proteins target and kill adenocarcinoma cells; the general use of pro-apoptotic proteins of the Bcl-2 family as novel killing components of targeting chimeric proteins.
    Azar Y; Lorberboum-Galski H
    Apoptosis; 2000 Dec; 5(6):531-42. PubMed ID: 11303912
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interleukin-13 receptor as a unique target for anti-glioblastoma therapy.
    Husain SR; Joshi BH; Puri RK
    Int J Cancer; 2001 Apr; 92(2):168-75. PubMed ID: 11291041
    [TBL] [Abstract][Full Text] [Related]  

  • 65. I.V. Administration of L-GNRH-PE66 efficiently inhibits growth of colon adenocarcinoma xenografts in nude mice.
    Ben-Yehudah A; Prus D; Lorberboum-Galski H
    Int J Cancer; 2001 Apr; 92(2):263-8. PubMed ID: 11291055
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy.
    Eaveri R; Ben-Yehudah A; Lorberboum-Galski H
    Curr Cancer Drug Targets; 2004 Dec; 4(8):673-87. PubMed ID: 15578922
    [TBL] [Abstract][Full Text] [Related]  

  • 67.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 68.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 69.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 70.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 71.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.